title: FXR activation inhibits inflammation and preserves the intestinal barrier in IBD.
authors.affiliation: Academic Medical Center, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Manon E
authors.initials: ME
authors.lastname: Wildenberg
authors.forename: Gijs R
authors.initials: GR
authors.lastname: van den Brink
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000503:physiopathology*; D007408:Intestinal Absorption / Q000502:physiology*; D051379:Mice; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000502:physiology*; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D005765:Gastrointestinal Agents; D018160:Receptors, Cytoplasmic and Nuclear; D000099150:Receptor, Farnesoid X-Activated